4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000842023-12-000021
VP Hematology Operations sold 475 shares at $67.57 ($32,096)
- VP Hematology Operations acquired 475 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
VERONNEAU MARCEL · VP Hematology Operations
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2012-08-14 | Exercise or conversion : show line 1 in the form | +475 | $51.60 | $24,510 | 35,044 | D |
| 2012-08-14 | Sale : show line 2 in the form | −475 | $67.57 | $32,096 | 34,569 | D |
| Open-market sales · 475 sh · avg $67.57 · $32,096 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-08-14 | Exercise or conversion : show line 3 in the form Stock Option | −475 | $51.60 | 2012-08-17 | 475 | 0 | D |
Loading xslF345X03/primary_doc.xml…